Jan. 5, 2023
Luis Santiago, CEO at PEGASI
Luis Santiago is PEGASI's CEO and CTO. By training, he is a social communicator and marketing and public relations professor. By profession, he is a self-taught programmer, technology project manager, and Product Owner, with more than 14 years of experience in the area. He has ventured into banking, IT, and Digital Health. Luis was recognized in 2016 as one of the Young Leaders of the Americas by the American State Department, and in 2020 as one of the 35 Innovators under 35 in Latin America by the MIT Technology Review magazine. He has participated in dozens of international forums and events pointing out the importance of Healthcare digitalization in Latin America.
WEBVTT
00:00:18.489 --> 00:00:19.929
Radio, Pandora or Deser.
00:00:20.460 --> 00:00:27.809
Welcome to the Latin Leaders Podcast, a conversation with leaders who have succeeded or plan to succeed in Latin America.
00:00:28.210 --> 00:00:31.129
Today, our guest is Luis Santiago.
00:00:31.969 --> 00:00:34.929
Luis is Peas, c e o and c t o.
00:00:35.810 --> 00:00:42.810
Luis was recognizing 2016 as one of the young leaders of the Americas by the American State Department.
00:00:42.810 --> 00:01:00.409
And in 2020, as one of the 35 innovators under 35 in Latin America by the M I T Technology Review Magazine, he has participated in doses of international forums and events pointing out the importance of healthcare digitalization in Latin America.
00:01:00.411 --> 00:01:02.210
So, Luis, it's great to have you here today.
00:01:02.210 --> 00:01:03.369
Welcome to the show.
00:01:04.319 --> 00:01:05.719
Thank you very much, Julio.
00:01:05.721 --> 00:01:11.480
It's great to be here and, and share this space that, uh, many leaders in the area have shared before.
00:01:11.650 --> 00:01:13.439
So it's a privilege anar.
00:01:13.689 --> 00:01:14.359
Awesome.
00:01:14.361 --> 00:01:15.040
Thank you for that.
00:01:15.040 --> 00:01:15.799
I appreciate it.
00:01:15.930 --> 00:01:17.640
So, Luis, tell us about your journey.
00:01:17.641 --> 00:01:19.799
How is it that you got to where you are?
00:01:21.170 --> 00:01:22.019
Well, thank you.
00:01:22.379 --> 00:01:27.659
Um, yeah, we pegasi have a background before working in the healthcare IT area.
00:01:27.661 --> 00:01:28.980
We had a company in Venezuela.
00:01:29.579 --> 00:01:35.540
Uh, we closed that company during 2017, of course, uh, due to the situation that we have in the country.
00:01:36.500 --> 00:01:46.620
Uh, at the time of closing, we had around 8,000 users that we had, uh, digitally transformed, uh, using EHRs in our Eerp software.
00:01:47.819 --> 00:01:51.939
And we were managing around two electronic medical records in the country.
00:01:53.060 --> 00:02:06.019
Um, so we were in contact during 1617 with many facilitators, and that said that it would be a great idea to extend what we were doing for Venezuela to the rest of the, of the region.
00:02:06.230 --> 00:02:14.939
So, um, afterwards, uh, in two 19 we got into startup Chile, which is a program that's conducted by the Chilean government.
00:02:15.740 --> 00:02:26.139
And, uh, we got some grant funding and we found here in CHI extended to the US and we're now covering five countries in Latin America with the services that we provide.
00:02:26.530 --> 00:02:27.330
Beautiful.
00:02:27.330 --> 00:02:27.689
Wow.
00:02:27.691 --> 00:02:28.930
That's quite impressive.
00:02:29.330 --> 00:02:29.409
.
00:02:29.810 --> 00:02:30.490
Thank you.
00:02:30.491 --> 00:02:34.650
I, I wasn't sure about the startup Chile part of your story.
00:02:34.651 --> 00:02:35.490
I didn't know about it.
00:02:35.491 --> 00:02:37.210
I don't remember that part of it.
00:02:37.211 --> 00:02:41.169
I mean, that's quite a program that Chile has is an example in Latin America.
00:02:41.860 --> 00:02:42.530
Exactly.
00:02:42.590 --> 00:02:45.849
And it, it's starting to, to be promoted to other countries.
00:02:46.009 --> 00:02:50.009
Actually, startup is starting to be a success case in, in many countries.
00:02:50.169 --> 00:02:50.889
In, in Latin America.
00:02:51.250 --> 00:02:56.409
Uh, we, we have the, the, the knowledge of, uh, certain programs in Columbia that are doing exactly the same.
00:02:56.889 --> 00:03:00.039
We have, uh, Puerto Rico's called, called parallel 18.
00:03:00.560 --> 00:03:05.240
Uh, the previous, uh, director was a director for Startup Chi as well.
00:03:05.349 --> 00:03:05.639
I
00:03:05.840 --> 00:03:06.240
Read it, yes.
00:03:06.560 --> 00:03:06.560
Yeah,
00:03:07.250 --> 00:03:07.919
Exactly.
00:03:08.319 --> 00:03:24.120
And, and it's a program that, um, these are programs are super essential, uh, in, uh, creating an ecosystem for, for startups to grow in those spaces and then start expanding from those specific countries and, and starting exporting other parts of America.
00:03:25.319 --> 00:03:37.800
So where, where we didn't see the opportunity in Venezuela inability of the country, we, we found opportunity and started more extending from chi to other parts of America emerge.
00:03:38.840 --> 00:03:38.840
Okay.
00:03:38.841 --> 00:03:39.400
Very good.
00:03:39.800 --> 00:03:41.719
Alright, so Luis, let's talk about trends.
00:03:42.199 --> 00:03:51.560
What, what do you see happening in Latin America, uh, from the political, economic, or social standpoint that is relevant to our discussion today?
00:03:52.590 --> 00:03:54.360
Well, and that's a great question.
00:03:54.759 --> 00:03:56.680
Um, we are currently focused on oncology.
00:03:57.000 --> 00:03:59.159
So I'm starting seeing the trends in the, in the area.
00:04:00.319 --> 00:04:06.039
Um, we, we recently were reviewing, uh, many of the reports from global, uh, starting.
00:04:08.439 --> 00:04:21.240
And we saw the number of cases in the cases in drastic, uh, one of the reasons cancer, some medical circles called, uh, middle class disease.
00:04:22.199 --> 00:04:26.560
Uh, cancer happens when you don't die, other things.
00:04:26.838 --> 00:04:26.838
So
00:04:27.350 --> 00:04:28.120
I didn't know that.
00:04:28.120 --> 00:04:29.160
I mean, that's fuzzy, maybe.
00:04:30.120 --> 00:04:31.120
So middle class disease,
00:04:31.759 --> 00:04:32.399
Exactly.
00:04:33.160 --> 00:04:46.959
It happens, for example, when you have Africa and Latin America, uh, overcoming diseases such as small books or, uh, dengue, malaria, uh, then people grow old enough to, to have cancer.
00:04:47.879 --> 00:04:51.199
Uh, in the case of Africa particularly, it's being called an epidemic.
00:04:51.519 --> 00:05:00.480
Right now you have around three and cases reported every year when there were 20 years ago, uh, or very few, many years ago.
00:05:00.879 --> 00:05:06.360
So in, in that sense, uh, Latin America is starting to see a huge trend in, in cancer developing in the region.
00:05:06.759 --> 00:05:12.439
Uh, the, the, the first and most prevalent one is, uh, breast cancer, and the second one is cervical cancer.
00:05:13.278 --> 00:05:22.759
In many cases, cervical cancer specifically is caused by classes 16, 18 high risk, uh, PPI virus.
00:05:23.379 --> 00:05:36.759
And of course, if you start seeing papillomavirus as something that's, uh, an, an sti uh, sexually transmitted disease, uh, std I'm sorry, then you start seeing the trend of, uh, how cancer spreads like an epidemic.
00:05:37.759 --> 00:05:56.160
So, uh, it, it's very interesting that, uh, when you start seeing the diseases that the, the people have, uh, then you start seeing that, uh, these diseases are related to overcoming, uh, extreme poverty in the region and, um, people increasing their lifespan.
00:05:56.449 --> 00:06:07.500
So you start seeing, uh, diseases that have been prevalent in the developed world, and they're starting to show up in the developing world, and we are prepared to deal with malaria.
00:06:07.588 --> 00:06:16.459
We are prepared to deal with, um, we are prepared to deal with, I don't know, small books, but we are not prepared to deal with cancer.
00:06:16.588 --> 00:06:25.180
So there's a huge trend in the developing world to start preparing for these, uh, middle class diseases.
00:06:26.620 --> 00:06:32.459
Um, and, and, and it's interesting because these are niche that are not developing medicine in the region.
00:06:32.819 --> 00:06:36.019
So there's a huge need for technology.
00:06:36.699 --> 00:06:45.579
There's a huge need for, for awareness, and there's a huge need for education of people to, in order to avoid, uh, developing these diseases
00:06:45.879 --> 00:06:48.500
And screening, I would say too, right?
00:06:48.850 --> 00:06:49.338
Yeah.
00:06:49.528 --> 00:07:13.810
I mean, innovative technologies, as you correctly said to screen patients, because now, um, you, we have, um, newer technologies, for example, just to give you an idea, I'm dealing with a client of us who has probably the only device in the world that can detect the change of temperature in the breast.
00:07:14.160 --> 00:07:14.649
Okay.
00:07:14.769 --> 00:07:18.370
Prior to, to a woman going to mammography.
00:07:19.019 --> 00:07:23.970
So you have this little device, it's a$10,$20 device that you get at the drugstore.
00:07:24.110 --> 00:07:40.529
You put it in the fridge, and just every three months or so, just, uh, put it next to your breast and then it will give you an indication of, uh, a change in temperature so that you have an alert, uh, you tell your doctor and then you get sent to mammography.
00:07:41.019 --> 00:07:41.930
So Exactly,
00:07:42.439 --> 00:07:42.930
Yeah.
00:07:43.290 --> 00:07:44.490
Another technologies like that I've
00:07:44.610 --> 00:07:46.170
Sent to, no, and, and it's amazing.
00:07:46.529 --> 00:07:49.410
Uh, these are very, very incredible technologies.
00:07:49.970 --> 00:08:05.170
Uh, the, one of the key advantages of technology is that, uh, the sooner you develop the, that technology and you have that technology in the market, uh, for longer lifespans, uh, then of course the technology can become cheaper.
00:08:05.170 --> 00:08:11.649
And it's something that's, uh, something that can be acquired and massified in the, the world, for example.
00:08:11.779 --> 00:08:12.449
Exactly.
00:08:12.451 --> 00:08:13.089
Exactly.
00:08:13.889 --> 00:08:17.649
Alright, Luis, so let's talk about what you guys are doing with psi.
00:08:17.680 --> 00:08:28.730
What problem are you guys trying to solve with the, the, the company and what challenges are you facing in doing business in, in Chile and the other countries in the region?
00:08:30.220 --> 00:08:31.779
No, that's great, and thank you for that question.
00:08:32.220 --> 00:08:46.178
Um, pretty much the thei is reducing, uh, time for, uh, cancer, um, diagnostic and time to treatment by half, uh, for the developing world.
00:08:47.379 --> 00:09:00.558
Um, this problem merges, like I I said before, there, there are some figures you have with cancer in 2020 and race between comes specifically for, from American Africa.
00:09:01.639 --> 00:09:16.799
And, uh, we have an disadvantage, uh, when for cancer detection treatment, 60 days, um, in Latin America, the meantime days.
00:09:17.558 --> 00:09:31.399
So there, there are some research that indicate that for every 30 days that you take patient reduced by.
00:09:33.769 --> 00:09:48.440
So yeah, you started with a handicap when dealing with cancer in our regions, you might have hundred, 2,050 days before you get a, a certain diagnosis, uh, from the patient.
00:09:49.129 --> 00:10:06.919
So, uh, that means that, uh, for regions such as Latin America, Africa, south Asia, dealing with cancer is even more expensive than, uh, not never to mention that the the dropping quality of care and quality of life for those patients, but it's actually more expensive.
00:10:07.440 --> 00:10:20.200
Cause when you start treating the patient, the patient is in a, in a stage that's further ahead, when you might have found them in the develop world, in stage one or two, you'll find them in stage three or four here in LA America.
00:10:20.970 --> 00:10:30.399
So what we developed is something that we saw in the region that was happening, this, uh, thing about moving cancer information from one place to the other.
00:10:30.678 --> 00:10:39.080
For example, if you have the suspicion that you have cancer, the first thing is to create a biopsy, uh, or, or to take a biopsy outta the tumor.
00:10:40.000 --> 00:10:50.470
And then you might take one day, two days analyzing the report, and then you have to wait for the patient to pick that report up and then take it to the physician so the physician can review it.
00:10:50.750 --> 00:10:53.350
And then this whole process takes 10 days.
00:10:54.230 --> 00:10:59.750
And then you start, you have the biopsy report and the physician says that he alarm.
00:11:00.389 --> 00:11:04.710
And now you have to the patient into the, as fast as possible.
00:11:05.350 --> 00:11:07.350
And that takes another days.
00:11:07.629 --> 00:11:17.389
So in the patient might have cancer and moment the patient is having the first went by.
00:11:18.279 --> 00:11:30.308
So what we created is, uh, pga an oncology information system that allows you to have everything that is connected to the patient's cancer suspicion in the same platform.
00:11:31.230 --> 00:11:36.470
And, uh, which, uh, first allows you the access to the information.
00:11:37.190 --> 00:11:44.549
Secondly, gives you all the alerts and warnings that, for example, a result is ready or a patient needs treatment at certain point.
00:11:45.308 --> 00:11:49.230
And third allows you to create statistics outta all information.
00:11:52.549 --> 00:11:59.399
Idea is to create, create this oncology information system that first allows you to control what's happening in the oncology institution.
00:11:59.720 --> 00:12:03.600
And second, and most importantly, is to connect all the dots.
00:12:04.639 --> 00:12:08.678
Then, uh, you have all the information that you need to make, uh, decision about the patient.
00:12:09.639 --> 00:12:15.320
So, uh, we started working in, in the first area that we touched was, uh, suspicion.
00:12:16.120 --> 00:12:19.558
Uh, we started working with, uh, screening protocols.
00:12:20.600 --> 00:12:25.159
Uh, the first one we launched, we launched in July, uh, July, 2020.
00:12:25.879 --> 00:12:27.440
In July, 2021, sorry.
00:12:28.080 --> 00:12:41.399
Uh, in, in Ecuador inka, we screened around 3000 women for human, uh, reported to the physician.
00:12:41.759 --> 00:12:53.120
The up on the infection that was found.
00:12:53.759 --> 00:12:55.440
This is high risk human virus.
00:12:55.720 --> 00:13:01.879
Uh, those patients are at risk of, uh, probabilities of developing, uh, cervical cancer.
00:13:03.159 --> 00:13:14.639
Um, we are also extending protocol to, you know, uh, in Latin America precursor, uh, lung cancer, uh, specifically in Chile.
00:13:15.080 --> 00:13:17.558
It's a very, very big problem due to contamination.
00:13:19.000 --> 00:13:47.600
And, um, then afterwards in the diagnosis and treatment phase, we created a platform called, uh, which allows physicians to, uh, remotely connect, uh, to discuss patient's, uh, case have all these, uh, assets, uh, in line for example, you have, uh, your mammographies or your immunology reports, your laboratory reports, your, um, anatomical path reports.
00:13:47.960 --> 00:13:52.759
If you have, uh, molecular screening of a patient, you have that available as well.
00:13:53.600 --> 00:14:10.440
So when you have that discussion, you have all the assets that you need, you create a treatment case or a treatment plan, and the platform administers the treatment plan and gives you warnings when this patient is supposed to have a chemotherapy or what is the, the expected date of the surgery for the patient.
00:14:11.200 --> 00:14:15.519
So it allows you to synchronize all the resources that you need to give attention to the patient.
00:14:16.330 --> 00:14:40.519
So, uh, in ensure, pretty much what we do is we collect all of that information and create a single pipeline, uh, to join the patient under care team in all of the patients, uh, uh, journey throughout cancer, hopefully, uh, joining them also in researching how they, uh, what result did they have from their treatment, and how that treatment will benefit a patient with the exact same type of cancer.
00:14:41.169 --> 00:14:57.039
So in the end, it's connecting enough information from a region that has 70% of that information in paper, uh, in order to create artificial intelligence that allows you to predict and prescribe the type of treatment for our patient, uh, a singular patient
00:14:58.299 --> 00:15:00.120
Who pays for this platform.
00:15:00.789 --> 00:15:01.710
Who's your client?
00:15:01.950 --> 00:15:01.950
Yeah,
00:15:03.350 --> 00:15:04.110
That, that's very interesting.
00:15:04.110 --> 00:15:08.870
We have, uh, different client, uh, we have a client and then we have an end user.
00:15:09.559 --> 00:15:10.230
Exactly.
00:15:10.230 --> 00:15:11.549
Yeah, I imagine that mm-hmm.
00:15:11.629 --> 00:15:11.629
.
00:15:11.789 --> 00:15:11.789
Yeah.
00:15:12.299 --> 00:15:12.789
Yeah.
00:15:13.269 --> 00:15:22.350
Um, currently we, most of our customers are, uh, pharma companies, uh, that are interested in conducting real data, real research.
00:15:23.269 --> 00:15:30.269
Uh, our biggest customer is we work Chile.
00:15:31.470 --> 00:15:41.149
Um, then, uh, with what we do with them is, uh, we created, uh, an r and d platform that allows, for example, a physician to interact with the patient, store that information.
00:15:41.509 --> 00:15:51.350
Then, uh, they send, uh, uh, consent form using the platform that is digital designed by the patient and allows their information to be used in clinical research.
00:15:51.950 --> 00:16:03.830
This is a completely automated, uh, process, and, uh, it gives the, the pharma, uh, a hassle free way to obtain high quality data to perform the research.
00:16:03.980 --> 00:16:04.830
Absolutely.
00:16:05.029 --> 00:16:05.029
Mm-hmm.
00:16:05.110 --> 00:16:05.110
.
00:16:05.230 --> 00:16:05.230
Yeah.
00:16:05.549 --> 00:16:13.509
So, so the, for the client, I'm sorry, for the end user, um, well, I, I, I, I take that back.
00:16:14.080 --> 00:16:29.100
So the platform is, is free or is easily accessible to a hospital, easily accessible to a, uh, a patient so that they can more freely enter the data because they are really the source of data.
00:16:29.200 --> 00:16:35.820
And then you sell that data to the pharmaceutical companies or whoever, industry
00:16:36.690 --> 00:16:37.379
E Exactly.
00:16:37.380 --> 00:16:40.580
We sell aggregated, anonymized analytics of that information.
00:16:41.740 --> 00:16:41.740
Yeah.
00:16:41.940 --> 00:16:43.259
We never sell the source information.
00:16:43.500 --> 00:16:45.659
We actually don't, we don't have access to it.
00:16:46.059 --> 00:16:51.700
Um, whenever we enter the platform, it creates, uh, its, uh, encrypted.
00:16:53.220 --> 00:16:55.740
Uh, there are two keys that can uncorrect the information.
00:16:55.740 --> 00:16:59.299
The first one is from the physician, and the other one is from the patient themselves.
00:17:00.419 --> 00:17:02.820
Uh, so we don't have anything that can identify a person.
00:17:03.740 --> 00:17:11.500
Uh, we create our protocols using aggregated information, and that is an information that we use, for example, to train artificial intelligence.
00:17:11.900 --> 00:17:17.299
Well, we have an alliance with a company in Spain that's, uh, with a company.
00:17:17.740 --> 00:17:23.460
We're trading artificial intelligence algorithms to predict the best course of treatment for, uh, breast cancer.
00:17:24.240 --> 00:17:26.980
And, um, there are many other things that you can do.
00:17:27.180 --> 00:17:36.819
For example, if you introduce a new medication or a new chemotherapy treatment for certain types of cancer, you can validate the results in actual patients.
00:17:37.740 --> 00:17:55.599
Um, and that, that's, uh, the idea of, uh, having clinical information as a source of truth, and giving physicians also interfaces allow to create high quality clinical data, uh, instead of, uh, just writing things down in, uh, unstructured processable performance.
00:17:56.029 --> 00:17:56.519
Yeah.
00:17:56.520 --> 00:18:16.200
But, but was the experience of the physician or the patient, uh, with the platform, because, uh, from the standpoint of a hospital or physician, don't they find this redundant to have to enter information in a electronic medical record platform, and then in your platform, I guess you're separate.
00:18:17.108 --> 00:18:18.009
How does it work?
00:18:18.010 --> 00:18:18.890
How's the adoption?
00:18:20.130 --> 00:18:21.730
The, the platform works as an emr.
00:18:22.049 --> 00:18:37.450
Uh, an e uh, we, we have, like, we were actually discussing this, well, one of the, uh, this morning, uh, they say, you don't, Eva, there's no way you can evade, uh, doing like ehr, e R P software development.
00:18:37.640 --> 00:18:42.569
I said, no, because most of the, uh, clinics in America are still on paper.
00:18:42.970 --> 00:18:52.930
Uh, there's a study from the, the international telecommunications that says that Latin America has like 3% of their clinical information still on paper.
00:18:53.289 --> 00:18:53.730
So,
00:18:54.329 --> 00:18:55.368
Um, wow.
00:18:55.690 --> 00:18:56.289
Yeah, case
00:18:56.769 --> 00:18:56.769
Far.
00:18:57.170 --> 00:18:57.170
If
00:18:57.250 --> 00:19:05.730
You wanna install, yeah, a beautiful tumor board that will allow you to discuss twice as much, uh, cases, twice as many cases, I'm sorry.
00:19:06.450 --> 00:19:14.049
And during the, the week, then, uh, you start seeing that for the Tmobile to work, you actually have to have digitized, uh, assets.
00:19:14.779 --> 00:19:24.410
So then you have to provide those physicians with some sort of, uh, tool to actually, uh, digitize the information.
00:19:24.470 --> 00:19:27.769
And then you have to install your, uh, his software.
00:19:28.150 --> 00:19:34.769
And then we, we started like working from the his, which is the base, and then we started adding like these cherries on top.
00:19:34.770 --> 00:19:37.809
Like for example, the tumor board, the screening platform.
00:19:38.108 --> 00:19:47.089
But you cannot have a screening platform or a tumor board if you don't have an, uh, so we have like two flavors.
00:19:48.089 --> 00:19:49.049
It depends on the institution.
00:19:49.250 --> 00:19:56.730
If they have a, is we create interfaces with their his to recover valid information to go into the tumor board.
00:19:56.940 --> 00:20:00.329
If you don't have a hip, no, a his, don't worry, we have you covered.
00:20:01.329 --> 00:20:05.690
And, uh, then we create an ecosystem for information to move in the clinic in a digital format.
00:20:06.608 --> 00:20:06.608
Okay.
00:20:06.618 --> 00:20:08.970
So right now, tray is cancer.
00:20:10.250 --> 00:20:16.849
Are you looking, uh, does your roadmap include other indications or other therapeutic areas?
00:20:18.089 --> 00:20:18.579
Yeah.
00:20:18.980 --> 00:20:35.099
Um, we currently are seeing the, uh, the space of chronic diseases in Latin America is the, in Africa as well is the least, the least inhabited, I'm sorry, by solutions, uh, because you don't have anyone that's integrating, uh, information in all of those spaces.
00:20:36.220 --> 00:20:43.579
Uh, we have had, um, proposals to, for example, this, uh, tuberculosis protocol, uh, respiratory diseases.
00:20:43.858 --> 00:20:45.579
There are, uh, prevalent in the region.
00:20:46.618 --> 00:20:51.240
Uh, we have had an invitation to do an Alzheimer long run test as well.
00:20:52.319 --> 00:20:56.880
Uh, so the, the space for chronic diseases is, uh, interesting.
00:20:57.240 --> 00:21:02.118
But the fact is that oncology is a very large niche in itself.
00:21:02.960 --> 00:21:07.319
And, uh, we see a huge impact opportunity, uh, oncology protocol.
00:21:08.240 --> 00:21:08.480
Excellent.
00:21:08.480 --> 00:21:09.118
Very good.
00:21:09.259 --> 00:21:10.118
Congratulations.
00:21:10.358 --> 00:21:11.519
It looks like a thank you.
00:21:11.589 --> 00:21:14.039
A promise in technology or platform.
00:21:14.380 --> 00:21:18.118
And what countries are you currently in right now in Latin America?
00:21:19.368 --> 00:21:21.200
We are operating in Chile.
00:21:21.680 --> 00:21:23.118
It's, uh, chiles, our headquarters.
00:21:23.599 --> 00:21:29.480
We are doing, uh, we're working inu, Dominican Republic.
00:21:30.079 --> 00:21:33.799
We have a, like three or four customers in Colombia.
00:21:34.759 --> 00:21:37.640
Uh, looking forward to expanding, uh, faster in Colombia.
00:21:38.750 --> 00:21:44.589
And we recently had interview with Primary care center in hon.
00:21:45.589 --> 00:21:50.910
They want to start using the platform, so probably gonna have a couple customers in Hons.
00:21:51.309 --> 00:22:05.390
Um, and, uh, then we're negotiating with our first customer in the us given that they have to, that takes a bit longer, but trying to have, we have few customers in many countries.
00:22:06.190 --> 00:22:15.829
The region, uh, every country that you see through is a, is a challenge because, uh, every country has different, uh, legislations.
00:22:15.830 --> 00:22:19.630
And then you have to make sure that you're not stepping anyone's sos.
00:22:20.589 --> 00:22:21.259
Exactly.
00:22:21.769 --> 00:22:22.259
Yeah.
00:22:22.500 --> 00:22:26.539
Uh, the, that's the next question that I have for you, Luis.
00:22:26.730 --> 00:22:28.858
Challenges and best practices.
00:22:29.539 --> 00:22:34.660
Uh, can we identify some ch common challenges, uh, uh, among all these countries?
00:22:34.730 --> 00:22:41.140
I mean, across the board, have you seen kind of a partner of, uh, of, of accessing the market?
00:22:41.430 --> 00:22:42.539
Is it the language?
00:22:42.700 --> 00:23:00.660
Every country has a different kind of dialect in Spanish, different way of doing things, or same things, uh, as you correctly said, the, uh, legislation, the regulations are a little different in every country in Latin America, and that's a big challenge in the region is so fragmented, right?
00:23:00.661 --> 00:23:06.779
So please speak about challenges and, and if you can give us some tips or best practices, that'll be ideal.
00:00:18.489 --> 00:00:19.929
00:00:20.460 --> 00:00:27.809
00:00:28.210 --> 00:00:31.129
00:00:31.969 --> 00:00:34.929
00:00:35.810 --> 00:00:42.810
00:00:42.810 --> 00:01:00.409
00:01:00.411 --> 00:01:02.210
00:01:02.210 --> 00:01:03.369
00:01:04.319 --> 00:01:05.719
00:01:05.721 --> 00:01:11.480
00:01:11.650 --> 00:01:13.439
00:01:13.689 --> 00:01:14.359
00:01:14.361 --> 00:01:15.040
00:01:15.040 --> 00:01:15.799
00:01:15.930 --> 00:01:17.640
00:01:17.641 --> 00:01:19.799
00:01:21.170 --> 00:01:22.019
00:01:22.379 --> 00:01:27.659
00:01:27.661 --> 00:01:28.980
00:01:29.579 --> 00:01:35.540
00:01:36.500 --> 00:01:46.620
00:01:47.819 --> 00:01:51.939
00:01:53.060 --> 00:02:06.019
00:02:06.230 --> 00:02:14.939
00:02:15.740 --> 00:02:26.139
00:02:26.530 --> 00:02:27.330
00:02:27.330 --> 00:02:27.689
00:02:27.691 --> 00:02:28.930
00:02:29.330 --> 00:02:29.409
00:02:29.810 --> 00:02:30.490
00:02:30.491 --> 00:02:34.650
00:02:34.651 --> 00:02:35.490
00:02:35.491 --> 00:02:37.210
00:02:37.211 --> 00:02:41.169
00:02:41.860 --> 00:02:42.530
00:02:42.590 --> 00:02:45.849
00:02:46.009 --> 00:02:50.009
00:02:50.169 --> 00:02:50.889
00:02:51.250 --> 00:02:56.409
00:02:56.889 --> 00:03:00.039
00:03:00.560 --> 00:03:05.240
00:03:05.349 --> 00:03:05.639
00:03:05.840 --> 00:03:06.240
00:03:06.560 --> 00:03:06.560
00:03:07.250 --> 00:03:07.919
00:03:08.319 --> 00:03:24.120
00:03:25.319 --> 00:03:37.800
00:03:38.840 --> 00:03:38.840
00:03:38.841 --> 00:03:39.400
00:03:39.800 --> 00:03:41.719
00:03:42.199 --> 00:03:51.560
00:03:52.590 --> 00:03:54.360
00:03:54.759 --> 00:03:56.680
00:03:57.000 --> 00:03:59.159
00:04:00.319 --> 00:04:06.039
00:04:08.439 --> 00:04:21.240
00:04:22.199 --> 00:04:26.560
00:04:26.838 --> 00:04:26.838
00:04:27.350 --> 00:04:28.120
00:04:28.120 --> 00:04:29.160
00:04:30.120 --> 00:04:31.120
00:04:31.759 --> 00:04:32.399
00:04:33.160 --> 00:04:46.959
00:04:47.879 --> 00:04:51.199
00:04:51.519 --> 00:05:00.480
00:05:00.879 --> 00:05:06.360
00:05:06.759 --> 00:05:12.439
00:05:13.278 --> 00:05:22.759
00:05:23.379 --> 00:05:36.759
00:05:37.759 --> 00:05:56.160
00:05:56.449 --> 00:06:07.500
00:06:07.588 --> 00:06:16.459
00:06:16.588 --> 00:06:25.180
00:06:26.620 --> 00:06:32.459
00:06:32.819 --> 00:06:36.019
00:06:36.699 --> 00:06:45.579
00:06:45.879 --> 00:06:48.500
00:06:48.850 --> 00:06:49.338
00:06:49.528 --> 00:07:13.810
00:07:14.160 --> 00:07:14.649
00:07:14.769 --> 00:07:18.370
00:07:19.019 --> 00:07:23.970
00:07:24.110 --> 00:07:40.529
00:07:41.019 --> 00:07:41.930
00:07:42.439 --> 00:07:42.930
00:07:43.290 --> 00:07:44.490
00:07:44.610 --> 00:07:46.170
00:07:46.529 --> 00:07:49.410
00:07:49.970 --> 00:08:05.170
00:08:05.170 --> 00:08:11.649
00:08:11.779 --> 00:08:12.449
00:08:12.451 --> 00:08:13.089
00:08:13.889 --> 00:08:17.649
00:08:17.680 --> 00:08:28.730
00:08:30.220 --> 00:08:31.779
00:08:32.220 --> 00:08:46.178
00:08:47.379 --> 00:09:00.558
00:09:01.639 --> 00:09:16.799
00:09:17.558 --> 00:09:31.399
00:09:33.769 --> 00:09:48.440
00:09:49.129 --> 00:10:06.919
00:10:07.440 --> 00:10:20.200
00:10:20.970 --> 00:10:30.399
00:10:30.678 --> 00:10:39.080
00:10:40.000 --> 00:10:50.470
00:10:50.750 --> 00:10:53.350
00:10:54.230 --> 00:10:59.750
00:11:00.389 --> 00:11:04.710
00:11:05.350 --> 00:11:07.350
00:11:07.629 --> 00:11:17.389
00:11:18.279 --> 00:11:30.308
00:11:31.230 --> 00:11:36.470
00:11:37.190 --> 00:11:44.549
00:11:45.308 --> 00:11:49.230
00:11:52.549 --> 00:11:59.399
00:11:59.720 --> 00:12:03.600
00:12:04.639 --> 00:12:08.678
00:12:09.639 --> 00:12:15.320
00:12:16.120 --> 00:12:19.558
00:12:20.600 --> 00:12:25.159
00:12:25.879 --> 00:12:27.440
00:12:28.080 --> 00:12:41.399
00:12:41.759 --> 00:12:53.120
00:12:53.759 --> 00:12:55.440
00:12:55.720 --> 00:13:01.879
00:13:03.159 --> 00:13:14.639
00:13:15.080 --> 00:13:17.558
00:13:19.000 --> 00:13:47.600
00:13:47.960 --> 00:13:52.759
00:13:53.600 --> 00:14:10.440
00:14:11.200 --> 00:14:15.519
00:14:16.330 --> 00:14:40.519
00:14:41.169 --> 00:14:57.039
00:14:58.299 --> 00:15:00.120
00:15:00.789 --> 00:15:01.710
00:15:01.950 --> 00:15:01.950
00:15:03.350 --> 00:15:04.110
00:15:04.110 --> 00:15:08.870
00:15:09.559 --> 00:15:10.230
00:15:10.230 --> 00:15:11.549
00:15:11.629 --> 00:15:11.629
00:15:11.789 --> 00:15:11.789
00:15:12.299 --> 00:15:12.789
00:15:13.269 --> 00:15:22.350
00:15:23.269 --> 00:15:30.269
00:15:31.470 --> 00:15:41.149
00:15:41.509 --> 00:15:51.350
00:15:51.950 --> 00:16:03.830
00:16:03.980 --> 00:16:04.830
00:16:05.029 --> 00:16:05.029
00:16:05.110 --> 00:16:05.110
00:16:05.230 --> 00:16:05.230
00:16:05.549 --> 00:16:13.509
00:16:14.080 --> 00:16:29.100
00:16:29.200 --> 00:16:35.820
00:16:36.690 --> 00:16:37.379
00:16:37.380 --> 00:16:40.580
00:16:41.740 --> 00:16:41.740
00:16:41.940 --> 00:16:43.259
00:16:43.500 --> 00:16:45.659
00:16:46.059 --> 00:16:51.700
00:16:53.220 --> 00:16:55.740
00:16:55.740 --> 00:16:59.299
00:17:00.419 --> 00:17:02.820
00:17:03.740 --> 00:17:11.500
00:17:11.900 --> 00:17:17.299
00:17:17.740 --> 00:17:23.460
00:17:24.240 --> 00:17:26.980
00:17:27.180 --> 00:17:36.819
00:17:37.740 --> 00:17:55.599
00:17:56.029 --> 00:17:56.519
00:17:56.520 --> 00:18:16.200
00:18:17.108 --> 00:18:18.009
00:18:18.010 --> 00:18:18.890
00:18:20.130 --> 00:18:21.730
00:18:22.049 --> 00:18:37.450
00:18:37.640 --> 00:18:42.569
00:18:42.970 --> 00:18:52.930
00:18:53.289 --> 00:18:53.730
00:18:54.329 --> 00:18:55.368
00:18:55.690 --> 00:18:56.289
00:18:56.769 --> 00:18:56.769
00:18:57.170 --> 00:18:57.170
00:18:57.250 --> 00:19:05.730
00:19:06.450 --> 00:19:14.049
00:19:14.779 --> 00:19:24.410
00:19:24.470 --> 00:19:27.769
00:19:28.150 --> 00:19:34.769
00:19:34.770 --> 00:19:37.809
00:19:38.108 --> 00:19:47.089
00:19:48.089 --> 00:19:49.049
00:19:49.250 --> 00:19:56.730
00:19:56.940 --> 00:20:00.329
00:20:01.329 --> 00:20:05.690
00:20:06.608 --> 00:20:06.608
00:20:06.618 --> 00:20:08.970
00:20:10.250 --> 00:20:16.849
00:20:18.089 --> 00:20:18.579
00:20:18.980 --> 00:20:35.099
00:20:36.220 --> 00:20:43.579
00:20:43.858 --> 00:20:45.579
00:20:46.618 --> 00:20:51.240
00:20:52.319 --> 00:20:56.880
00:20:57.240 --> 00:21:02.118
00:21:02.960 --> 00:21:07.319
00:21:08.240 --> 00:21:08.480
00:21:08.480 --> 00:21:09.118
00:21:09.259 --> 00:21:10.118
00:21:10.358 --> 00:21:11.519
00:21:11.589 --> 00:21:14.039
00:21:14.380 --> 00:21:18.118
00:21:19.368 --> 00:21:21.200
00:21:21.680 --> 00:21:23.118
00:21:23.599 --> 00:21:29.480
00:21:30.079 --> 00:21:33.799
00:21:34.759 --> 00:21:37.640
00:21:38.750 --> 00:21:44.589
00:21:45.589 --> 00:21:50.910
00:21:51.309 --> 00:22:05.390
00:22:06.190 --> 00:22:15.829
00:22:15.830 --> 00:22:19.630
00:22:20.589 --> 00:22:21.259
00:22:21.769 --> 00:22:22.259
00:22:22.500 --> 00:22:26.539
00:22:26.730 --> 00:22:28.858
00:22:29.539 --> 00:22:34.660
00:22:34.730 --> 00:22:41.140
00:22:41.430 --> 00:22:42.539
00:22:42.700 --> 00:23:00.660
00:23:00.661 --> 00:23:06.779